Developing 2 Uni-Vect systems to combine a constitutive HER2-targeting CAR with NFAT-inducible FOXO1 or TCF7, researchers validated improved proliferation and persistence of CAR-T cells in ovarian tumors (127). This evidence concerns the gene ERBB2 and ovarian neoplasm.